Sarepta Therapeutics: Funding, Investors & Team (Oct 2026)
Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing. It was founded in 1980 and headquartered in Cambridge, Massachusetts.
Sarepta Therapeutics has raised $506M across 2 funding rounds on record, the most recent a Post-IPO Equity of $6.0M announced in Sep 2022.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sarepta Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Sarepta Therapeutics Funding Rounds
Sarepta Therapeutics raised $500M in a Post-IPO Equity announced in Oct 2021.
11 months later, a Post-IPO Equity of $6.0M was announced in Sep 2022.
Sarepta Therapeutics Founders and Leadership Team
Contact details for the Sarepta Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Sarepta Therapeutics Funding Compared to Other Biotechnology Startups
Sarepta Therapeutics' latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sarepta Therapeutics in Biotechnology and Cambridge
Companies Similar to Sarepta Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Sarepta Therapeutics Funding FAQs
What does Sarepta Therapeutics do?
Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing. It was founded in 1980 and headquartered in Cambridge, Massachusetts.
How much funding has Sarepta Therapeutics raised?
Sarepta Therapeutics has raised $506M across 2 rounds on record. The most recent is a Post-IPO Equity of $6.0M announced in Sep 2022.
When did Sarepta Therapeutics last raise funding?
Sarepta Therapeutics' most recent funding round on record is a Post-IPO Equity of $6.0M, announced in Sep 2022.
Who is the CEO of Sarepta Therapeutics?
Douglas S Ingram is listed as CEO at Sarepta Therapeutics.
Where is Sarepta Therapeutics headquartered?
Sarepta Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Sarepta Therapeutics have?
Sarepta Therapeutics is in the 501-1000 employee band.
How does Sarepta Therapeutics' funding compare to other Biotechnology startups?
Sarepta Therapeutics' latest round of $6.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Sarepta Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sarepta Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.